Browsing Tag
NASDAQ
289 posts
From IPO to $250M shelf: Can BioAge Labs keep investor faith in the race for anti-aging drugs?
BioAge Labs (NASDAQ: BIOA) files $250M mixed securities shelf to fuel its aging drug pipeline. See what it means for investors today.
Why Eos Energy’s 7.33m-share filing could reshape its stock outlook in 2025
Eos Energy Enterprises files to sell 7.33M shares. Learn how the equity raise impacts dilution, growth runway, and EOSE stock sentiment.
Range Capital Acquisition Corp. II prices $200m IPO — What it means for SPAC investors and Nasdaq sentiment
Range Capital Acquisition Corp. II prices $200M IPO on Nasdaq — see how this SPAC plans to hunt deals and why investors are watching its next move.
Nanyang Biologics to list via $1.5bn SPAC — What it means for The9 investors and biotech markets
The9-backed Nanyang Biologics plans a $1.5B SPAC listing on Nasdaq. Find out what this means for AI drug discovery, The9’s stock, and investors.
Why Viomi Technology’s Nasdaq compliance matters more than just avoiding delisting
Viomi Technology (NASDAQ: VIOT) regains Nasdaq compliance. See why it matters for investors, stock sentiment, governance, and the water purification industry.
Germany’s DeepL eyes $5bn U.S. IPO — Can it really rival Google and Microsoft in AI translation?
DeepL is considering a $5B U.S. IPO to expand its AI translation and agent business—find out how this move could reshape the language tech industry.
From zero revenue to $13bn valuation: What Fermi’s blockbuster debut tells investors about AI data centers
Fermi’s IPO soared 19% above its issue price, spotlighting investor appetite for AI-driven infrastructure. Find out what this REIT debut means for markets today.
Alphabet’s cloud layoffs explained: How Wall Street is reading GOOGL’s efficiency push
Alphabet (NASDAQ: GOOGL) trims jobs in Google Cloud amid efficiency push. Explore what it means for investors, enterprise clients, and AI competition.
Fermi America prices IPO at $21 per share ahead of Nasdaq and London listings
Fermi America prices IPO at $21, dual-listing on Nasdaq and London. Find out why investors see FRMI as a bold bet on AI-driven energy grids.
Texas Stock Exchange gains SEC approval, opening a new era of competition in U.S. capital markets
The SEC has approved TXSE Group’s Texas Stock Exchange, creating new competition for NYSE and Nasdaq. Find out how TXSE could reshape U.S. markets.